Analysis of Urinary Escherichia coli Isolates for Ability To Produce Shiga Toxin

ABSTRACT The frequency of Shiga toxin (Stx)-producing Escherichia coli (STEC) in the urinary tract, which can precipitate the hemolytic-uremic syndrome, is unknown. We tested 597 urinary E. coli isolates by Stx immunoassay and found no STEC. The routine screening of urinary E. coli for the ability to produce Stx is not warranted.

[1]  A. Friedrich,et al.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. , 2002, The Journal of infectious diseases.

[2]  M. Hogan,et al.  Two cases of non-O157:H7 Escherichia coli hemolytic uremic syndrome caused by urinary tract infection. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  J. R. Johnson,et al.  Ongoing Horizontal and Vertical Transmission of Virulence Genes and papA Alleles among Escherichia coliBlood Isolates from Patients with Diverse-Source Bacteremia , 2001, Infection and Immunity.

[4]  J. R. Johnson,et al.  Clonal relationships and extended virulence genotypes among Escherichia coli isolates from women with a first or recurrent episode of cystitis. , 2001, The Journal of infectious diseases.

[5]  G. Procop,et al.  The low prevalence of shiga-toxin production among sorbitol non-fermenting Escherichia coli urinary tract isolates does not warrant routine screening. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  F. Scheutz,et al.  Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Craig S. Wong,et al.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. , 2000, The New England journal of medicine.

[8]  J. R. Johnson,et al.  Molecular Epidemiological and Phylogenetic Associations of Two Novel Putative Virulence Genes, iha and iroNE. coli, among Escherichia coli Isolates from Patients with Urosepsis , 2000, Infection and Immunity.

[9]  J. Reuning-Scherer,et al.  Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women , 2000 .

[10]  T. R. Ward,et al.  Iha: a Novel Escherichia coli O157:H7 Adherence-Conferring Molecule Encoded on a Recently Acquired Chromosomal Island of Conserved Structure , 2000, Infection and Immunity.

[11]  F. Grimont,et al.  Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. R. Johnson,et al.  Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. , 2000, The Journal of infectious diseases.

[13]  J. R. Johnson papG Alleles among Escherichia coli Strains Causing Urosepsis: Associations with Other Bacterial Characteristics and Host Compromise , 1998, Infection and Immunity.

[14]  T. D. de Koning-Ward,et al.  Hemolytic-uremic syndrome following urinary tract infection with enterohemorrhagic Escherichia coli: case report and review. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  J. Maslow,et al.  Clonal distribution of the three alleles of the Gal(alpha1-4)Gal-specific adhesin gene papG among Escherichia coli strains from patients with bacteremia. , 1998, The Journal of infectious diseases.

[16]  J. R. Johnson,et al.  papG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. , 1998, The Journal of infectious diseases.

[17]  A. Stapleton,et al.  Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. , 1996, The New England journal of medicine.

[18]  T. Whittam,et al.  Clonal relationships among bloodstream isolates of Escherichia coli , 1995, Infection and immunity.

[19]  J. R. Johnson,et al.  O, K, and H antigens predict virulence factors, carboxylesterase B pattern, antimicrobial resistance, and host compromise among Escherichia coli strains causing urosepsis. , 1994, The Journal of infectious diseases.

[20]  R. Arbeit,et al.  Bacterial adhesins and host factors: role in the development and outcome of Escherichia coli bacteremia. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Stapleton,et al.  Lack of circumcision increases the risk of urinary tract infection in young men. , 1992, JAMA.

[22]  S. Moseley,et al.  Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. , 1991, The Journal of infectious diseases.

[23]  P. Tarr,et al.  Escherichia coli 0157:H7 and the Hemolytic Uremic Syndrome: Importance of Early Cultures in Establishing the Etiology , 1990 .

[24]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[25]  J. R. Johnson,et al.  Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics , 1988, Infection and immunity.

[26]  H. Ochman,et al.  Standard reference strains of Escherichia coli from natural populations , 1984, Journal of bacteriology.

[27]  C. Yiannoutsos,et al.  Testing of Urinary Escherichia coli Isolates for Shiga Toxin Production , 2022 .